ITGAX and colitis: Our previous work also demonstrated that peroral administration of L. reuteri reduces pro-inflammatory CD11b+CD11c+ DCs in mesenteric lymph nodes (MLNs), key sources of inflammatory cytokines—while expanding Foxp3+CD4+ T cells during colitis [21].